Abstract
A new prenylated acridone alkaloid, medicacridone (1), and a new ferulate xanthone, medicaxanthone (5), together with 11 known compounds were isolated from the methanol extract of the bark of the Cameroonian medicinal plant Citrus medica. The structures of all compounds were determined by comprehensive analyses of their 1D and 2D NMR, mass spectral (EI and ESI) data, chemical reactions, and comparison with previously known analogues. The agar diffusion test delivered low to missing antimicrobial activities, corresponding with MICs > 1 mg mL–1, while compounds 1–6 and atalantoflavone (9) displayed weak cytotoxic activity against the human Caucasian prostate adenocarcinoma cell line PC-3, with IC50 values ranging from 60.5 to 80.0 μm
versus doxorubicine with IC50=0.9 μm.
摘要:从喀麦隆药用植物柚子(Citrus medica)的树皮甲醇提取物中分离出一种新的异戊二烯基喹啉生物碱medicacridone(1)和一种新的ferulate黄酮medicaxanthone(5),以及11种已知化合物。通过对它们的1D和2D NMR、质谱(EI和ESI)数据、化学反应和与先前已知的类似物的比较进行全面分析,确定了所有化合物的结构。琼脂扩散试验显示抗微生物活性低或缺失,相应的最小抑菌浓度(MICs)大于1 mg mL–1,而化合物1-6和atalantoflavone(9)对人类高加索前列腺腺癌细胞系PC-3显示出较弱的细胞毒性活性,IC50值在60.5到80.0 μm范围内,与doxorubicin的IC50=0.9 μm相比。